APPLICATION
NDA020962
TYPE
NDA
ORIGINAL APPROVAL
1998-02-04
LATEST ACTION
2002-10-09
ROUTE
TOPICAL
DOSAGE FORM
DISC
MARKETING STATUS
Discontinued
Products
EMLADiscontinued
LIDOCAINE 2.5%, PRILOCAINE 2.5% · DISC · TOPICAL
Approval history
2002-10-09Manufacturing (CMC) · Supplement 2 · standardAP
2002-02-15Manufacturing (CMC) · Supplement 3 · standardAP
2000-04-20Labeling · Supplement 1 · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.